Wei Zhang
16PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Mar 03, 2026
Combined oral PI3Kδ inhibitor linperlisib and HDAC inhibitor chidamide in relapsed/refractory peripheral T-cell lymphoma: a multicenter phase 1 trial.Chong Wei, Liping Su, Lihong Liu
|Sep 03, 2025
Successful Treatment of Diffuse Large B-Cell Lymphoma and Antisynthetase Syndrome with Bispecific Antibody Glofitamab.Chong Wei, Mei Zhang, Danqing Zhao
|Jun 24, 2025
Germline defects of familial haemophagocytic lymphohistiocytosis-Related genes may represent a predisposing factor for mature T- and natural killer-cell lymphoma.Chong Wei, Yan Zhang, Danqing Zhao
|Jul 26, 2024
Plasma circulating tumour DNA is a better source for diagnosis and mutational analysis of IVLBCL than tissue DNA.Chao Chen, Yiao Di, Zhe Zhuang
|May 13, 2024
The role of upfront lenalidomide maintenance for primary central nervous system lymphoma following first-line methotrexate treatment: A retrospective study.Yan Zhang, Wei Wang, Danqing Zhao
|Dec 14, 2023
The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma.Jinrong Zhao, Chong Wei, Shuqing Wang
Pageof 3
